Email This Article

Headlines & Perspectives
For Imclone, It's ASCO and Ye Shall Receive
By Adam Feuerstein
05/14/01 - 10:30 AM EDT
Strong drug results reported to the American Society of Clinical Oncology send the biotech higher.
Recipient's Email Address(es)
(Separate multiple addresses with a comma)
Your Email Address
Send a copy to myself
Your Message (optional)
Your Recent Quotes: Quote Up0 | Quote Down0
Dow S&P 500 NASDAQ
Oil*
Gold
10 Yr
0.00%
%
%
%
Data delayed 20 min
Premium Stock Ideas